Anomalous aortic origin of coronary arteries: Early results on clinical management from an international multicenter study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 21 12 2018
accepted: 04 02 2019
pubmed: 18 2 2019
medline: 15 5 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Anomalous aortic origin of coronary arteries (AAOCA) is a rare abnormality, whose optimal management is still undefined. We describe early outcomes in patients treated with different management strategies. This is a retrospective clinical multicenter study including patients with AAOCA, undergoing or not surgical treatment. Patients with isolated high coronary take off and associated major congenital heart disease were excluded. Preoperative, intraoperative, anatomical and postoperative data were retrieved from a common database. Among 217 patients, 156 underwent Surgical repair (median age 39 years, IQR: 15-53), while 61 were Medical (median age 15 years, IQR: 8-52), in whom AAOCA was incidentally diagnosed during screening or clinical evaluations. Surgical patients were more often symptomatic when compared to medical ones (87.2% vs 44.3%, p < 0.001). Coronary unroofing was the most frequent procedure (56.4%). Operative mortality was 1.3% (2 patients with preoperative severe heart failure). At a median follow up of 18 months (range 0.1-23 years), 89.9% of survivors are in NYHA ≤ II, while only 3 elderly surgical patients died late. Return to sport activity was significantly higher in Surgical patients (48.1% vs 18.2%, p < 0.001). Surgery for AAOCA is safe and with low morbidity. When compared to Medical patients, who remain on exercise restriction and medical therapy, surgical patients have a benefit in terms of symptoms and return to normal life. Since the long term-risk of sudden cardiac death is still unknown, we currently recommend accurate long term surveillance in all patients with AAOCA.

Sections du résumé

BACKGROUND
Anomalous aortic origin of coronary arteries (AAOCA) is a rare abnormality, whose optimal management is still undefined. We describe early outcomes in patients treated with different management strategies.
METHODS
This is a retrospective clinical multicenter study including patients with AAOCA, undergoing or not surgical treatment. Patients with isolated high coronary take off and associated major congenital heart disease were excluded. Preoperative, intraoperative, anatomical and postoperative data were retrieved from a common database.
RESULTS
Among 217 patients, 156 underwent Surgical repair (median age 39 years, IQR: 15-53), while 61 were Medical (median age 15 years, IQR: 8-52), in whom AAOCA was incidentally diagnosed during screening or clinical evaluations. Surgical patients were more often symptomatic when compared to medical ones (87.2% vs 44.3%, p < 0.001). Coronary unroofing was the most frequent procedure (56.4%). Operative mortality was 1.3% (2 patients with preoperative severe heart failure). At a median follow up of 18 months (range 0.1-23 years), 89.9% of survivors are in NYHA ≤ II, while only 3 elderly surgical patients died late. Return to sport activity was significantly higher in Surgical patients (48.1% vs 18.2%, p < 0.001).
CONCLUSIONS
Surgery for AAOCA is safe and with low morbidity. When compared to Medical patients, who remain on exercise restriction and medical therapy, surgical patients have a benefit in terms of symptoms and return to normal life. Since the long term-risk of sudden cardiac death is still unknown, we currently recommend accurate long term surveillance in all patients with AAOCA.

Identifiants

pubmed: 30772012
pii: S0167-5273(18)37161-4
doi: 10.1016/j.ijcard.2019.02.007
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-193

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Massimo A Padalino (MA)

Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School, Italy. Electronic address: massimo.padalino@unipd.it.

Nicola Franchetti (N)

Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School, Italy.

George E Sarris (GE)

Athens Heart Surgery Institute and Iaso Children's Hospital, Athens, Greece.

Mark Hazekamp (M)

Department for Cardiovascular Surgery, University Medical Center, Leiden, the Netherlands.

Thierry Carrel (T)

Department for Cardiovascular Surgery, University Hospital Bern and University of Bern, Bern, Switzerland.

Alessandro Frigiola (A)

Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Jurgen Horer (J)

Department of Pediatric Cardiology and Congenital Heart Disease, Hôpital Marie Lannelongue, Université Paris-Sud, Le Plessis-Robinson, France.

Regine Roussin (R)

Department of Pediatric Cardiology and Congenital Heart Disease, Hôpital Marie Lannelongue, Université Paris-Sud, Le Plessis-Robinson, France.

Julie Cleuziou (J)

Deutsch Herz Zentrum, Munich, Germany.

Bart Meyns (B)

Katholieke Universiteit Leuven, Leuven, Belgium.

Jose Fragata (J)

Cardiothoracic Surgery Hospital de Santa Marta Rua de Santa Marta Lisbon, Portugal.

Helena Telles (H)

Cardiothoracic Surgery Hospital de Santa Marta Rua de Santa Marta Lisbon, Portugal.

Anastasios C Polimenakos (AC)

Department of Pediatric Cardiothoracic Surgery, Children's Hospital of Georgia, Augusta, GA, USA.

Katrien Francois (K)

Department of Cardiac Surgery, University Hospital Ghent, Ghent, Belgium.

Altin Veshti (A)

Division of Cardiac Surgery, University Hospital Center of Tirana, Tirana, Albania.

Jukka Salminen (J)

Department of Pediatric Cardiac Surgery, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.

Alvaro Gonzalez Rocafort (AG)

Congenital Cardiac Surgery Department, Hospital Universitario La Paz, Madrid, Spain.

Matej Nosal (M)

Department of Pediatric Cardiac Surgery, National Institute of Cardio-Vascular Diseases - Childrens Heart Center, Bratislava, Slovakia.

Luca Vedovelli (L)

PCare Laboratory, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.

Eleftherios Protopapas (E)

Athens Heart Surgery Institute and Iaso Children's Hospital, Athens, Greece.

Roberto Tumbarello (R)

Division of Pediatric Cardiology, Ospedale Brotzu, Cagliari, Italy.

Assunta Merola (A)

Division of Pediatric Cardiology, Ospedale Brotzu, Cagliari, Italy.

Cinzia Pegoraro (C)

Division of Sport Medicine, Ospedale Ca Foncello, Treviso, Italy.

Raffaella Motta (R)

Radiology Clinic, University of Padova, Medical School, Italy.

Giovanna Boccuzzo (G)

Department of Statistics, University of Padova, Medical School, Italy.

Vladimir Sojak (V)

Department for Cardiovascular Surgery, University Medical Center, Leiden, the Netherlands.

Mauro Lo Rito (ML)

Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Federica Caldaroni (F)

Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Domenico Corrado (D)

Section of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School, Italy.

Cristina Basso (C)

Section of Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School, Italy.

Giovanni Stellin (G)

Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH